Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
AEterna Zentaris, Inc. (NASDAQ: AEZS)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
Æterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology
Nov 11, 2009 08:36 AM |
AEZ
,
AEZS
,
KERX
Æterna Zentaris: son partenaire Keryx Biopharmaceuticals fera une présentation sur affiche portant sur l'activité clinique de perifosine (KRX-0401) à la 51ième assemblée annuelle de l'American Society of Hematology
Nov 11, 2009 08:36 AM |
AEZ
,
AEZS
,
KERX
AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology
Nov 11, 2009 08:35 AM |
AEZ
,
AEZS
,
KERX
Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Nov 11, 2009 08:30 AM |
AEZS
,
KERX
Æterna Zentaris Reports Third Quarter 2009 Financial and Operating Results
Nov 11, 2009 07:03 AM |
AEZ
,
AEZS
,
KERX
,
MRK
Æterna Zentaris annonce ses résultats financiers et d'exploitation du troisième trimestre de 2009
Nov 11, 2009 07:02 AM |
AEZ
,
AEZS
,
KERX
,
MRK
AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results
Nov 11, 2009 07:01 AM |
AEZ
,
AEZS
,
KERX
AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer
Nov 09, 2009 07:05 AM |
AEZ
,
AEZS
,
KERX
AEterna Zentaris to Announce Third Quarter 2009 Financial and Operating Results on November 11, 2009
Nov 04, 2009 07:02 AM |
AEZ
,
AEZS
AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer
Nov 02, 2009 07:01 AM |
AEZ
,
AEZS
More..
AEterna Zentaris Raises $5.5 Million in Registered Direct Offering
Oct 26, 2009 10:51 AM |
AEZS
AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results
Aug 11, 2009 07:57 AM |
AEZS
,
KERX
AEterna Zentaris Raises $10 Million in Financing
Jun 25, 2009 11:53 AM |
AEZS
,
RODM
AEterna Zentaris to Raise US$10 Million From Institutional Investors at US$1.88 Per Share
Jun 19, 2009 09:54 AM |
AEZS
,
RODM
AEterna Zentaris Reports First Quarter 2009 Financial and Operating Results
May 06, 2009 07:52 AM |
AEZS
AEterna Zentaris Q4 Revenues Slide
Mar 11, 2009 08:13 AM |
AEZS
AEterna Zentaris, Sanofi-Aventis to Jointly Develop and Market Cetrorelix
Mar 06, 2009 07:55 AM |
AEZ
,
AEZS
,
SNY
More..
AEterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference
Sep 01, 2009 07:00 AM |
AEZ
,
AEZS
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
Aug 17, 2009 02:00 AM |
AEZ
,
AEZS
AEterna Zentaris to Present at Upcoming Canaccord Adams 29th Annual Global Growth Conference
Aug 06, 2009 07:00 AM |
AEZ
,
AEZS
AEterna Zentaris to Announce Second Quarter 2009 Financial and Operating Results on August 11, 2009
Aug 05, 2009 07:01 AM |
AEZ
,
AEZS
AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
Aug 03, 2009 08:35 AM |
AEZ
,
AEZS
AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction
Jul 07, 2009 07:15 AM |
AEZ
,
AEZS
AEterna Zentaris Receives US$10 Million From Institutional Investors
Jun 24, 2009 03:00 PM |
AEZS
,
RODM
AEterna Zentaris to Raise US$10 Million From Institutional Investors at US$1.88 Per Share
Jun 19, 2009 12:52 PM |
AEZS
,
RODM
AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule
Jun 15, 2009 07:16 AM |
AEZ
,
AEZS
AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia
Jun 10, 2009 07:16 AM |
AEZ
,
AEZS
More..
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
AEZS
Compare to S&P
YTD
102.04 %
67.21 %
4 Weeks
-9.17 %
-10.15 %
12 Weeks
10.64 %
4.31 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
20.83 %
EPS Growth in Last Year:
26.92 %
Sales Growth in Last Quarter:
2.22 %
Sales Growth in Last Quarter:
-22.34 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
